{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:50:19Z","timestamp":1789775419640,"version":"4.0.1"},"reference-count":78,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1517\/14656566.9.4.625","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T07:11:36Z","timestamp":1204528296000},"page":"625-633","source":"Crossref","is-referenced-by-count":27,"title":["Doxazosin in the current treatment of hypertension"],"prefix":"10.1517","volume":"9","author":[{"given":"Andrzej","family":"Wykretowicz","sequence":"first","affiliation":[{"name":"Poznan University of Medical Sciences, Department of Cardiology \u2013 Intensive Therapy, 49 Przybyszewskiego Street, 60-355 Poznan, Poland ; ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Guzik","sequence":"additional","affiliation":[{"name":"Poznan University of Medical Sciences, Department of Cardiology \u2013 Intensive Therapy, 49 Przybyszewskiego Street, 60-355 Poznan, Poland ; ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Wysocki","sequence":"additional","affiliation":[{"name":"Poznan University of Medical Sciences, Department of Cardiology \u2013 Intensive Therapy, 49 Przybyszewskiego Street, 60-355 Poznan, Poland ; ;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2008,3,3]]},"reference":[{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"key":"e_1_3_1_4_1","first-page":"1462","volume":"28","author":"Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28(12):1462-536","journal-title":"Eur Heart J"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.2.141"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03307-9"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00067.x"},{"key":"e_1_3_1_8_1","first-page":"I131","author":"Grimm","year":"1989","unstructured":"Grimm RH Jr. Alpha 1-antagonists in the treatment of hypertension. Hypertension 1989;13(5 Suppl):I131-6","journal-title":"Hypertension"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199549020-00011"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2004.07.005"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.5414\/CPP44099"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199506000-00018"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(05)80074-8"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200306000-00006"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.1.54"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2005.05300.x"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(00)00109-4"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.1967"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2006.04811.x"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000202562.46420.d9"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/08038020310016369"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67185-1"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2000.36.10.599206"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500787"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342110-00001"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00225-3"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126097-200306000-00005"},{"key":"e_1_3_1_28_1","first-page":"69S","author":"Torvik","year":"1986","unstructured":"Torvik D, Madsbu HP. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension. Br J Clin Pharmacol 1986;21(Suppl 1):69S-75S","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90160-3"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(97)80130-0"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90858-F"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00615226"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1989.tb03299.x"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00614546"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(95)00439-4"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.3.698"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.18.125"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1081\/CEH-57438"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.153"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1081\/CBI-120037772"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000086521.95630.5A"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/1468-6708-3-10"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/CVM-2-6-249"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/CVM-2-6-254"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00279-4"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(88)90237-2"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(88)90235-9"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00315116"},{"key":"e_1_3_1_49_1","first-page":"S362","author":"Brown","year":"1991","unstructured":"Brown MJ, Dickerson JE. Synergism between alpha 1-blockade and angiotensin converting enzyme inhibition in essential hypertension. J Hypertens 1991;9(6 Suppl):S362-3","journal-title":"J Hypertens"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90864-E"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199204000-00002"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.3.375"},{"key":"e_1_3_1_53_1","unstructured":"Opie LH. Mechanism of cardiac contraction and relaxation. Chapter 19. In: Braunwald's Heart Disease A Textbook of Cardiovascular Medicine. Zipes DP Libby P Bonow RO Braunwald E editors. Elsevier Saunders; 2005. p. 457-89"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.301"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7521.859"},{"key":"e_1_3_1_56_1","first-page":"S3","author":"Chang","year":"2006","unstructured":"Chang CL, Poulter NR, Chapman N, et al. The effect on blood pressure and lipid profiles of doxazosin GITS as a third-line agent in the ASCOT-BPLA trial. J Hypertens 2006;24:S3. Abstract 1A.3","journal-title":"J Hypertens"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(02)00797-2"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.588020"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0b013e3281eb8e8d"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.151746"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(99)00057-X"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/7.2.159"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.157404"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2005.04.005"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000403200214"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200626090-00006"},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(93)90196-U"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(95)90127-2"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(03)00190-2"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-200502000-00012"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.25.5"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02980.x"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.31.443"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(96)00289-0"},{"key":"e_1_3_1_75_1","first-page":"57","volume":"20","author":"Toth","year":"1999","unstructured":"Toth K, Nemes J, Czopf L, et al. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension. Clin Hemorheol Microcirc 1999;20(1):57-61","journal-title":"Clin Hemorheol Microcirc"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(96)00208-7"},{"key":"e_1_3_1_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02114-3"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030656"},{"key":"e_1_3_1_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1543-5946(05)00031-0"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.07.013"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.9.4.625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:44:06Z","timestamp":1770396246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.9.4.625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1517\/14656566.9.4.625"],"URL":"https:\/\/doi.org\/10.1517\/14656566.9.4.625","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}